Annals of Clinical and Laboratory Research

  • ISSN: 2386-5180
  • Journal h-index: 19
  • Journal CiteScore: 5.42
  • Journal Impact Factor: 4.64
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
+44 7460731551
Awards Nomination
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Directory of Research Journal Indexing (DRJI)
  • Publons
  • Euro Pub
  • Google Scholar
  • Secret Search Engine Labs
  • Zenodo
Share This Page

Perspective - (2023) Volume 11, Issue 4

Evaluating Hepatitis Clinical Trials: An Analysis of Gender Disparities in Women's Health Outcomes

Guan Jenniey*
Department of Psychiatry, University of Toronto, Ontario, Canada
*Correspondence: Guan Jenniey, Department of Psychiatry, University of Toronto, Ontario, Canada, Email:

Published: 25-Jul-2023, DOI: 10.36648/2386- 5180.23.11.476


High-level biosafety laboratories, such as Biosafety Level 3 (BSL-3) and Biosafety Level 4 (BSL-4) facilities play a critical role in conducting research and diagnostic activities on dangerous pathogens. Ensuring the safety and accuracy of operations within these laboratories is paramount. Quality Assurance (QA) and Quality Control (QC) practices are essential components of maintaining operational excellence and mitigating risks associated with hazardous agents. This article explores the significance of QA and QC in high-level biosafety laboratory operations, highlighting their roles, principles and implementation strategies. Quality assurance encompasses all systematic activities that ensure laboratories consistently meet established standards and guidelines. In high-level biosafety laboratories, QA is vital for guaranteeing the safety of personnel, maintaining the integrity of research results and ensuring compliance with regulatory requirements [1].

Documented standard operating procedures (Sops): SOPs provide detailed instructions for routine laboratory activities, ensuring that procedures are conducted consistently, safely and accurately. QA involves the development review and revision of SOPs to reflect best practices and regulatory standards.

Training and competency: QA programs should emphasize continuous training and competency assessment for laboratory staff. Properly trained personnel are better equipped to handle hazardous agents and adhere to safety protocols, reducing the risk of accidents or errors.

Equipment calibration and maintenance: QA requires regular calibration, maintenance and validation of laboratory equipment and instruments to ensure accurate and reliable results. This includes routine checks, performance verification and documentation of any repairs or adjustments [2].

Facility and biosafety assessments: Regular inspections and audits of laboratory facilities are essential to identify potential hazards, assess compliance with biosafety guidelines and implement corrective actions. QA programs should conduct thorough assessments of facility infrastructure, waste management and emergency response protocols.

Quality control involves the application of measures to monitor and verify the accuracy and precision of laboratory tests and procedures. In high-level biosafety laboratories, QC is crucial to ensure the reliability of diagnostic results and research outcomes. Key elements of QC in these facilities include [3].

Internal quality control (Iqc): IQC involves the use of known samples or controls to monitor the performance of laboratory tests. These controls should mimic patient samples and be tested alongside them to assess the accuracy and precision of the assays. Results are compared to predefined acceptance criteria and corrective actions are taken if deviations occur.

External quality assessment (EQA): EQA programs involve participation in proficiency testing schemes organized by external agencies. These programs provide an external validation of laboratory performance by comparing results with other laboratories. EQA helps identify systematic errors, assess inter-laboratory variability and benchmark performance against established standards.

Data integrity and documentation: Quality control requires accurate and complete documentation of all laboratory activities, including sample handling, test results and quality control records. Robust data management systems should be in place to ensure traceability, prevent data manipulation and facilitate data analysis and review [4, 5].


In high-level biosafety laboratories, QA and QC practices are indispensable for maintaining operational excellence and mitigating risks associated with hazardous pathogens. Through the implementation of comprehensive QA programs, laboratories can ensure adherence to standard operating procedures, personnel competency, equipment reliability and facility safety. Simultaneously, robust QC measures, such as IQC, EQA and diligent data management, enhance the accuracy and reliability of diagnostic and research outcomes. By prioritizing QA and QC, high-level biosafety laboratories can safeguard personnel safety, protect public health and advance scientific knowledge in a secure environment.


  1. Camacho-Feliciano DM, Pacheco-Acosta E, Morales B, et al (2013). Eliminating Health Disparities in Women's Health in Puerto Rico. J Health Care Poor Underserved. 24(4):159-67.
  2. Indexed at, Google Scholar, Cross Ref

  3. Chalaka CW, Mahurin HM, Tarabadkar E, Hippe DS, Loggers ET, et al (2023). Gender disparities in health-related quality of life (HRQoL) in patients with cutaneous T-cell lymphoma. Int J Women's Dermatol. 9(2):085.
  4. Indexed at, Google Scholar, Cross Ref

  5. Cortese DK, Szczypka G, Emery S, Wang S, Hair E, et al (2018). Smoking selfies: using Instagram to explore young women’s smoking behaviors. 4(3):2056305118790762.
  6. Indexed at, Google Scholar, Cross Ref

  7. Sorensen C, Saunik S, Sehgal M (2018). Climate change and women's health: Impacts and opportunities in India. Geo Health. 2(10):283-97.
  8. Indexed at, Google Scholar, Cross Ref

  9. Zhang GQ, Ozuygur Ermis SS, Radinger M (2022). Sex disparities in asthma development and clinical outcomes: implications for treatment strategies. J Asthma Allergy. 231-47.
  10. Indexed at, Google Scholar, Cross Ref

Citation: Jenniey G (2023) Evaluating Hepatitis Clinical Trials: An Analysis of Gender Disparities in Women's Health Outcomes. Ann Clin Lab Res. Vol.11 No.4:476